Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer

Abstract

TILs and CD8⁺ T cells provide additional prognostic value to the established clinical prognostic markers in TNBC. However, possible clinical applications would still benefit from systematic guidelines for evaluating tumor inflammatory response. Increasing understanding on the interactions between the regulation of cancer cell proliferation and inflammatory response may in future advance treatment of TNBC.